Table 7.
Metabolites and their pathways which correlate with autism symptoms.
Significant Metabolites | Significant Pathways | |||
---|---|---|---|---|
Metabolite | r | Pathway | Matched Metabolites | Impact |
Phenylpyruvic acid *** | −0.44 | Glyoxylate and dicarboxylate Metabolism *** |
Citrate *,
L-Serine **, Glycine *,
Isocitrate *, L-Glutamine * |
0.18 |
Cytidine *** | 0.42 | |||
5-Aminolevulinic acid *** | −0.39 | Valine, leucine and isoleucine Biosynthesis ** |
3-Methyl-2-oxobutanoic acid *,
4-Methyl-2-oxopentanoate *** |
0 |
3S-methyl-2-oxo-pentanoic acid *** | −0.38 | |||
4-Hydroxyproline ** | −0.36 | Aminoacyl-tRNA biosynthesis ** |
L-Glutamine *, Glycine *,
L-Serine **, L-Alanine * |
0.17 |
L-3-Phenyllactic acid ** | −0.36 | |||
Taurine ** | 0.35 | Alanine, aspartate and glutamate Metabolism * |
L-Alanine *, L-Glutamine *, Citrate * | 0.11 |
Citraconic acid ** | −0.35 | |||
Ketoleucine ** | −0.35 | Glycine, serine and threonine Metabolism * |
L-Serine **, Glycine *,
5-Aminolevulinate *** |
0.46 |
1-Methylhistamine ** | 0.33 | |||
D-Leucic acid ** | −0.32 | Pentose and glucuronate Interconversions * |
Xylitol *, D-Glucuronate ** | 0.3 |
Glucuronic acid ** | −0.32 | |||
Amiloride ** | 0.30 | Citrate cycle (TCA Cycle) * | Isocitrate *, Citrate * | 0.14 |
L-Serine ** | 0.29 | |||
Xylitol * | 0.29 | |||
Isocitric acid * | −0.28 | |||
Glycine * | 0.27 | |||
DL-Acetylcarnitine * | 0.25 | |||
L-Glutamine * | 0.25 | |||
Dihydroxyacetone * | 0.25 | |||
trans-Aconitic acid * | −0.25 | |||
Citric acid * | −0.25 | |||
Capric acid * | −0.24 | |||
L-Alanine * | −0.24 | |||
2-Aminoisobutyric acid * | 0.24 | |||
Isobutyric acid * | 0.23 | |||
2,3,4,5-Tetrahydroxypentanoic acid * | 0.23 | |||
4-Pyridoxic acid * | 0.23 | |||
D-Ribose 5-phosphate * | 0.23 | |||
Alpha-ketoisovaleric acid * | −0.22 |
* p ≤ 0.05, ** p ≤ 0.01; *** p ≤ 0.001.